A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models.
2021
SUMOylation, the covalent conjugation of small ubiquitin-like modifier (SUMO) proteins to protein substrates, has been reported to suppress type I interferon (IFN1) responses. TAK-981, a selective ...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
53
References
1
Citations
NaN
KQI